glucagon has been researched along with sdz co 611 in 1 studies
Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (sdz co 611) | Trials (sdz co 611) | Recent Studies (post-2010) (sdz co 611) |
---|---|---|---|---|---|
26,039 | 1,498 | 3,054 | 5 | 1 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bloom, SR; Ghatei, MA; Gwilliam, ME; Hammond, PJ; Khandan-Nia, N; Myers, MJ; Nelson-Piercy, C | 1 |
1 trial(s) available for glucagon and sdz co 611
Article | Year |
---|---|
Effect of a new oral somatostatin analog (SDZ CO 611) on gastric emptying, mouth to cecum transit time, and pancreatic and gut hormone release in normal male subjects.
Topics: Administration, Oral; Adult; Blood Glucose; Cecum; Dose-Response Relationship, Drug; Double-Blind Method; Esophagus; Gastric Emptying; Gastrins; Gastrointestinal Motility; Glucagon; Glucose Tolerance Test; Humans; Insulin; Intestines; Male; Motilin; Mouth; Octreotide; Pancreatic Polypeptide; Somatostatin; Stomach; Time Factors | 1994 |